
UnitedHealth Group (UNH) Stock
UnitedHealth Group Chart
Company Profile
Price: $529.44
Market Cap: $487.24B
Exchange: NYSE
CEO: Sir Andrew Philip Witty
Sector: Healthcare
Industry: Medical - Healthcare Plans
Employees: 440.00K
Headquarters: Minnetonka, MN
Website: UnitedHealth Group
Business Summary
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
UnitedHealth Group News
UnitedHealth raises concerns over Bill Ackman's post on X with SEC
UnitedHealth has reached out to the U.S. Securities and Exchange Commission about billionaire investor Bill Ackman's now-deleted post on social media platform X that said he would take a short position in the healthcare conglomerate.

2 Top Dividend Stocks to Buy If You Have $1,000 to Invest
Buying top dividend stocks and holding them long-term can be a great approach to building your investment portfolio. It boils down to holding shares of companies that have historically provided reliable dividends (as well as dividend growth) in all sorts of market environments.

U.S. & Europe Ambulatory Surgery Centers Market 2025-2030, Featuring Analysis of Leading Players - Envision Healthcare, TH Medical, Pediatrix Medical Group, TeamHealth, UnitedHealth Group & More
Orthopedics accounted for the largest revenue share of 26.7% in 2024. The integration of AI-driven platforms and advanced analytics to enhance care coordination and surgical outcomes is a key driving factor for this segment. Orthopedics accounted for the largest revenue share of 26.7% in 2024. The integration of AI-driven platforms and advanced analytics to enhance care coordination and surgical outcomes is a key driving factor for this segment.

Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Change Healthcare Breach Impacted 190 Million Americans
The biggest medical-related data breach in U.S. history was even larger than first estimated. The ransomware attack on UnitedHealth's Change Healthcare business last year impacted around 190 million people, almost double past estimates, TechCrunch reported Friday (Jan. 24).

US drops appeal in case over UnitedHealth Medicare plans' rating
The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the public star ratings it gave to UnitedHealth's privately administered Medicare health insurance plans, which the insurer said would cost it millions of dollars from lost customers.

UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing
UnitedHealthcare tapped Tim Noel, a company veteran, as its new CEO following the fatal, targeted shooting of its former top executive, Brian Thompson, in Manhattan in December. Noel served as the head of Medicare and Retirement at UnitedHealthcare, the largest private health insurer in the U.S. and the insurance arm of UnitedHealth Group.

3 Unstoppable Dividend Stocks That Can Be Pillars to Build Your Portfolio Around
If you're a new investor, want some recurring dividend income, or just want some top stocks to build your portfolio around, it's important to focus on businesses with strong fundamentals and room to generate steady growth for years to come.

UnitedHealth: Challenging Times Trigger A Contrarian Buy Opportunity
UNH has been sold off, thanks to the market's overreaction to the FQ4'24 top-line miss and mixed FY2025 guidance, as medical costs continue to grow. Despite headwinds, robust growth in Optum Rx and OptumHealth segments may balance UnitedHealthcare challenges, supporting the management's ambitious FY2025 targets. The consensus downgrades and UNH's discounted valuations highlight the market's pessimism, with it presenting a contrarian Buy opportunity.

Buy, Sell, Or Hold UNH Stock At $510?
UnitedHealth Group (NYSE: UNH) recently reported its Q4 results, with revenues missing and earnings exceeding the street expectations. The company reported revenue of $100.8 billion and adjusted earnings of $6.81 per share, compared to the consensus estimates of $101.8 billion and $6.72, respectively.

UnitedHealth Group Earnings
This section highlights UnitedHealth Group's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-01-16 | $6.74 | $6.81 |
Read Transcript | Q3 | 2024 | 2024-10-15 | $7.00 | $7.15 |
Read Transcript | Q2 | 2024 | 2024-07-16 | $6.65 | $6.80 |
Read Transcript | Q1 | 2024 | 2024-04-16 | $6.61 | $6.91 |
Read Transcript | Q4 | 2023 | 2024-01-12 | $5.98 | $6.16 |
Read Transcript | Q3 | 2023 | 2023-10-13 | $6.32 | $6.56 |
Read Transcript | Q2 | 2023 | 2023-07-14 | $5.99 | $6.14 |
Read Transcript | Q1 | 2023 | 2023-04-14 | $6.13 | $6.26 |
Financial Statements
Access annual & quarterly financial statements for UnitedHealth Group, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Revenue | $400.28B | $367.53B | $322.13B | $285.27B | $255.64B |
Cost of Revenue | $310.88B | $280.66B | $244.54B | $217.94B | $190.14B |
Gross Profit | $89.40B | $86.87B | $77.59B | $67.33B | $65.50B |
Gross Profit Ratio | 22.33% | 23.64% | 24.09% | 23.60% | 25.62% |
Research and Development Expenses | $- | $- | $- | $- | $- |
General and Administrative Expenses | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $57.11B | $54.63B | $- | $- | $- |
Other Expenses | $- | $-117.00M | $3.40B | $3.10B | $2.89B |
Operating Expenses | $57.11B | $54.51B | $51.18B | $45.68B | $44.59B |
Cost and Expenses | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B |
Interest Income | $- | $- | $- | $- | $- |
Interest Expense | $-3.91B | $3.25B | $2.09B | $1.66B | $1.66B |
Depreciation and Amortization | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B |
EBITDA | $9.77B | $32.52B | $31.84B | $27.07B | $25.30B |
EBITDA Ratio | 2.44% | 8.85% | 9.25% | 8.68% | 9.31% |
Operating Income | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B |
Operating Income Ratio | 8.07% | 8.80% | 8.83% | 8.40% | 8.76% |
Total Other Income Expenses Net | $-12.22B | $-3.25B | $-2.09B | $-1.66B | $-1.66B |
Income Before Tax | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B |
Income Before Tax Ratio | 5.01% | 7.92% | 8.18% | 7.82% | 8.11% |
Income Tax Expense | $-4.83B | $5.97B | $5.70B | $4.58B | $4.97B |
Net Income | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B |
Net Income Ratio | 3.60% | 6.09% | 6.25% | 6.06% | 6.03% |
EPS | $15.51 | $24.12 | $21.54 | $18.33 | $16.28 |
EPS Diluted | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 |
Weighted Average Shares Outstanding | 929.00M | 928.00M | 934.00M | 943.00M | 946.00M |
Weighted Average Shares Outstanding Diluted | 929.00M | 938.00M | 950.00M | 956.00M | 961.00M |
SEC Filing | Source | Source | Source | Source | Source |
Income Statement Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $100.81B | $100.82B | $97.86B | $98.78B | $93.25B | $91.36B | $91.79B | $91.13B | $82.79B | $80.89B | $80.33B | $80.15B | $73.74B | $72.34B | $71.32B | $70.20B | $65.47B | $65.11B | $62.14B | $64.42B |
Cost of Revenue | $79.50B | $77.79B | $76.80B | $76.79B | $72.42B | $68.97B | $70.02B | $69.25B | $61.91B | $60.94B | $60.69B | $61.01B | $56.16B | $55.10B | $54.21B | $52.48B | $49.70B | $49.57B | $42.18B | $48.69B |
Gross Profit | $21.31B | $23.03B | $21.06B | $21.99B | $20.82B | $22.39B | $21.77B | $21.88B | $20.88B | $19.95B | $19.64B | $19.14B | $17.58B | $17.23B | $17.11B | $17.72B | $15.76B | $15.54B | $19.96B | $15.73B |
Gross Profit Ratio | 21.14% | 22.84% | 21.52% | 22.26% | 22.33% | 24.51% | 23.72% | 24.01% | 25.22% | 24.67% | 24.45% | 23.88% | 23.84% | 23.82% | 24.00% | 25.24% | 24.08% | 23.87% | 32.12% | 24.42% |
Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $13.54B | $13.28B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Expenses | $- | $- | $1.02B | $997.00M | $974.00M | $14.86B | $1.02B | $970.00M | $982.00M | $828.00M | $802.00M | $788.00M | $771.00M | $796.00M | $778.00M | $758.00M | $732.00M | $719.00M | $717.00M | $723.00M |
Operating Expenses | $13.54B | $12.68B | $14.18B | $15.07B | $14.31B | $14.86B | $14.83B | $14.60B | $13.99B | $12.49B | $12.51B | $12.19B | $12.04B | $11.52B | $11.14B | $10.98B | $12.25B | $10.89B | $10.72B | $10.74B |
Cost and Expenses | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | $73.20B | $73.20B | $68.20B | $66.62B | $65.34B | $63.46B | $61.95B | $60.46B | $52.90B | $59.42B |
Interest Income | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Interest Expense | $-1.00B | $1.07B | $985.00M | $844.00M | $830.00M | $834.00M | $828.00M | $754.00M | $676.00M | $516.00M | $467.00M | $433.00M | $431.00M | $422.00M | $410.00M | $397.00M | $401.00M | $395.00M | $430.00M | $437.00M |
Depreciation and Amortization | $1.04B | $1.04B | $1.02B | $997.00M | $974.00M | $1.01B | $1.02B | $970.00M | $982.00M | $828.00M | $802.00M | $788.00M | $771.00M | $796.00M | $778.00M | $758.00M | $732.00M | $719.00M | $717.00M | $723.00M |
EBITDA | $4.57B | $9.73B | $7.67B | $1.84B | $7.48B | $8.54B | $9.08B | $9.06B | $7.87B | $8.29B | $7.93B | $7.74B | $6.31B | $6.51B | $6.76B | $7.50B | $4.25B | $5.37B | $9.96B | $5.72B |
EBITDA Ratio | 4.54% | 9.65% | 8.07% | 8.01% | 8.03% | 9.34% | 8.68% | 9.06% | 9.51% | 10.25% | 9.88% | 9.65% | 8.56% | 9.00% | 9.47% | 10.68% | 6.49% | 8.25% | 16.03% | 8.88% |
Operating Income | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | $7.13B | $6.95B | $5.54B | $5.71B | $5.98B | $6.74B | $3.52B | $4.65B | $9.24B | $5.00B |
Operating Income Ratio | 7.71% | 8.64% | 8.05% | 8.03% | 8.25% | 9.33% | 8.78% | 8.87% | 8.32% | 9.22% | 8.88% | 8.67% | 7.51% | 7.90% | 8.38% | 9.60% | 5.37% | 7.14% | 14.87% | 7.76% |
Total Other Income Expenses Net | $-982.00M | $-1.09B | $-2.21B | $-7.93B | $-830.00M | $-834.00M | $-828.00M | $-754.00M | $-676.00M | $-516.00M | $-467.00M | $-433.00M | $-431.00M | $-422.00M | $-410.00M | $-397.00M | $-401.00M | $-395.00M | $-430.00M | $-437.00M |
Income Before Tax | $6.79B | $7.61B | $5.67B | $1.00M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | $6.67B | $6.52B | $5.11B | $5.29B | $5.57B | $6.34B | $3.12B | $4.26B | $8.81B | $4.56B |
Income Before Tax Ratio | 6.74% | 7.55% | 5.79% | 0.00% | 7.36% | 8.42% | 7.88% | 8.05% | 7.51% | 8.59% | 8.30% | 8.13% | 6.93% | 7.31% | 7.81% | 9.03% | 4.76% | 6.54% | 14.18% | 7.08% |
Income Tax Expense | $-1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | $1.47B | $1.37B | $919.00M | $1.10B | $1.20B | $1.36B | $764.00M | $1.00B | $2.12B | $1.09B |
Net Income | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | $5.07B | $5.03B | $4.07B | $4.09B | $4.27B | $4.86B | $2.21B | $3.17B | $6.64B | $3.38B |
Net Income Ratio | 5.50% | 6.01% | 4.31% | -1.43% | 5.85% | 6.39% | 5.96% | 6.16% | 5.75% | 6.50% | 6.31% | 6.27% | 5.52% | 5.65% | 5.98% | 6.93% | 3.38% | 4.87% | 10.68% | 5.25% |
EPS | $5.98 | $6.56 | $4.58 | $-1.53 | $5.90 | $6.31 | $5.89 | $6.01 | $5.10 | $5.63 | $5.42 | $5.35 | $4.33 | $4.34 | $4.52 | $5.15 | $2.34 | $3.34 | $6.99 | $3.57 |
EPS Diluted | $5.98 | $6.51 | $4.54 | $-1.53 | $5.83 | $6.24 | $5.82 | $5.95 | $5.03 | $5.55 | $5.34 | $5.27 | $4.26 | $4.28 | $4.46 | $5.08 | $2.30 | $3.30 | $6.91 | $3.52 |
Weighted Average Shares Outstanding | 927.00M | 923.00M | 921.00M | 920.00M | 924.00M | 926.00M | 930.00M | 933.00M | 934.00M | 935.00M | 935.00M | 939.00M | 941.00M | 942.00M | 943.00M | 944.00M | 946.00M | 949.00M | 950.00M | 947.00M |
Weighted Average Shares Outstanding Diluted | 927.00M | 930.00M | 928.00M | 922.00M | 935.00M | 936.00M | 940.00M | 943.00M | 947.00M | 948.00M | 950.00M | 954.00M | 955.00M | 955.00M | 956.00M | 957.00M | 961.00M | 962.00M | 960.00M | 962.00M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B |
Short Term Investments | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B |
Cash and Short Term Investments | $29.63B | $27.91B | $23.91B | $19.78B | $14.24B |
Net Receivables | $38.97B | $30.45B | $28.08B | $25.40B | $21.46B |
Inventory | $- | $- | $- | $- | $- |
Other Current Assets | $9.84B | $10.71B | $9.77B | $8.53B | $6.93B |
Total Current Assets | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B |
Property Plant Equipment Net | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B |
Goodwill | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B |
Intangible Assets | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B |
Goodwill and Intangible Assets | $118.93B | $107.75B | $85.84B | $82.19B | $76.01B |
Long Term Investments | $- | $43.73B | $43.11B | $41.24B | $37.21B |
Tax Assets | $- | $2.77B | $-94.81B | $-90.82B | $-84.71B |
Other Non-Current Assets | $64.91B | $12.26B | $107.33B | $102.33B | $94.05B |
Total Non-Current Assets | $195.28B | $176.64B | $150.45B | $143.57B | $131.25B |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B |
Account Payables | $31.96B | $56.77B | $49.13B | $44.37B | $40.70B |
Short Term Debt | $4.27B | $3.11B | $3.62B | $4.82B | $3.87B |
Tax Payables | $- | $- | $- | $- | $- |
Deferred Revenue | $3.35B | $3.08B | $2.57B | $2.84B | $2.62B |
Other Current Liabilities | $59.47B | $26.28B | $22.98B | $20.39B | $14.60B |
Total Current Liabilities | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B |
Long Term Debt | $62.12B | $54.51B | $42.38B | $38.65B | $36.81B |
Deferred Revenue Non-Current | $3.35B | $2.77B | $-3.27B | $-3.37B | $-2.99B |
Deferred Tax Liabilities Non-Current | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B |
Other Non-Current Liabilities | $11.94B | $15.61B | $15.05B | $15.68B | $13.14B |
Total Non-Current Liabilities | $80.44B | $70.12B | $57.44B | $54.33B | $49.95B |
Other Liabilities | $-4.70B | $- | $- | $- | $- |
Total Liabilities | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B |
Preferred Stock | $- | $- | $- | $- | $2.81B |
Common Stock | $9.00M | $9.00M | $10.00M | $10.00M | $9.00M |
Retained Earnings | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B |
Accumulated Other Comprehensive Income Loss | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B |
Other Total Stockholders Equity | $- | $- | $- | $- | $7.00M |
Total Stockholders Equity | $88.76B | $77.77B | $71.76B | $65.49B | $60.44B |
Total Equity | $98.92B | $86.35B | $76.48B | $70.54B | $62.16B |
Total Liabilities and Stockholders Equity | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B |
Minority Interest | $10.16B | $8.57B | $4.72B | $5.05B | $1.73B |
Total Liabilities and Total Equity | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B |
Total Investments | $4.20B | $71.64B | $45.65B | $44.10B | $40.47B |
Total Debt | $62.54B | $57.62B | $46.00B | $43.47B | $40.68B |
Net Debt | $37.11B | $34.26B | $24.63B | $26.55B | $29.69B |
Balance Sheet Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $29.11B | $32.40B | $26.29B | $28.41B | $25.43B | $38.91B | $46.28B | $46.50B | $23.36B | $38.84B | $24.61B | $25.48B | $21.38B | $21.09B | $19.83B | $19.95B | $16.92B | $17.55B | $22.33B | $21.57B |
Short Term Investments | $- | $4.73B | $5.04B | $4.30B | $4.20B | $5.18B | $46.28B | $46.50B | $4.55B | $3.68B | $3.35B | $2.91B | $2.53B | $2.79B | $2.73B | $2.96B | $2.86B | $3.26B | $3.27B | $2.88B |
Cash and Short Term Investments | $29.11B | $37.13B | $31.32B | $32.71B | $29.63B | $44.10B | $46.28B | $46.50B | $27.91B | $42.53B | $27.96B | $28.40B | $23.91B | $23.87B | $22.56B | $22.92B | $19.78B | $20.81B | $25.59B | $24.45B |
Net Receivables | $22.36B | $47.48B | $49.88B | $46.48B | $38.97B | $38.42B | $34.08B | $37.11B | $17.68B | $30.73B | $31.16B | $30.86B | $14.22B | $28.23B | $27.22B | $27.53B | $12.87B | $25.40B | $23.98B | $24.89B |
Inventory | $- | $- | $- | $-74.89B | $-68.60B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Current Assets | $34.30B | $7.64B | $10.84B | $9.75B | $9.84B | $9.38B | $9.51B | $10.29B | $23.48B | $9.68B | $9.23B | $9.77B | $23.64B | $9.51B | $9.14B | $9.06B | $21.07B | $8.61B | $9.35B | $9.47B |
Total Current Assets | $85.78B | $92.26B | $92.04B | $88.94B | $78.44B | $91.91B | $89.87B | $93.89B | $69.07B | $82.94B | $68.36B | $69.03B | $61.76B | $61.61B | $58.92B | $59.51B | $53.72B | $54.82B | $58.92B | $58.81B |
Property Plant Equipment Net | $- | $10.14B | $9.80B | $10.43B | $11.45B | $11.07B | $10.93B | $10.64B | $10.13B | $9.47B | $9.42B | $9.18B | $8.97B | $8.73B | $8.73B | $8.50B | $8.63B | $8.15B | $8.13B | $8.17B |
Goodwill | $- | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | $84.16B | $77.55B | $75.80B | $75.44B | $75.83B | $72.16B | $71.34B | $68.09B | $67.87B | $65.30B |
Intangible Assets | $- | $23.59B | $14.73B | $15.54B | $15.19B | $15.20B | $15.64B | $16.16B | $14.40B | $10.79B | $11.29B | $9.92B | $10.04B | $10.44B | $10.81B | $10.84B | $10.86B | $10.37B | $10.55B | $10.20B |
Goodwill and Intangible Assets | $- | $129.57B | $120.17B | $121.21B | $118.93B | $116.90B | $117.31B | $116.57B | $107.75B | $94.69B | $95.44B | $87.47B | $85.84B | $85.87B | $86.63B | $83.00B | $82.19B | $78.46B | $78.42B | $75.50B |
Long Term Investments | $52.35B | $48.69B | $46.11B | $5.50B | $47.61B | $45.47B | $45.99B | $46.88B | $43.73B | $41.56B | $42.43B | $42.35B | $43.11B | $44.78B | $44.06B | $42.41B | $41.24B | $39.18B | $36.78B | $36.58B |
Tax Assets | $- | $4.01B | $3.63B | $4.17B | $4.70B | $2.21B | $2.50B | $2.83B | $4.60B | $1.66B | $2.58B | $2.95B | $-94.81B | $3.65B | $3.64B | $3.60B | $-90.82B | $3.34B | $3.29B | $3.03B |
Other Non-Current Assets | $160.15B | $18.65B | $14.31B | $53.96B | $17.30B | $14.50B | $13.57B | $12.86B | $10.43B | $12.75B | $11.94B | $10.25B | $107.33B | $8.41B | $8.31B | $8.15B | $102.33B | $7.01B | $6.95B | $6.98B |
Total Non-Current Assets | $212.50B | $207.05B | $194.02B | $195.27B | $199.98B | $190.16B | $190.29B | $189.78B | $176.64B | $160.13B | $161.82B | $152.21B | $150.45B | $151.44B | $151.38B | $145.66B | $143.57B | $136.15B | $133.56B | $130.26B |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $298.28B | $299.31B | $286.06B | $284.21B | $278.42B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | $221.24B | $212.21B | $213.04B | $210.29B | $205.17B | $197.29B | $190.97B | $192.48B | $189.07B |
Account Payables | $- | $- | $63.43B | $64.77B | $31.96B | $63.96B | $61.46B | $61.66B | $56.77B | $56.30B | $54.12B | $53.73B | $49.13B | $24.29B | $23.01B | $47.83B | $44.37B | $42.34B | $44.62B | $45.62B |
Short Term Debt | $4.54B | $3.91B | $11.37B | $9.79B | $5.31B | $5.29B | $6.32B | $9.93B | $3.11B | $3.23B | $5.59B | $6.70B | $3.62B | $3.62B | $3.87B | $8.84B | $4.82B | $3.90B | $6.16B | $15.83B |
Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $3.32B | $2.57B | $3.21B | $3.35B | $15.31B | $14.85B | $14.49B | $3.08B | $12.85B | $2.21B | $2.67B | $2.57B | $2.56B | $2.37B | $2.61B | $2.84B | $2.39B | $2.30B | $2.51B |
Other Current Liabilities | $99.22B | $94.34B | $27.29B | $26.67B | $58.43B | $29.62B | $30.34B | $30.40B | $26.28B | $28.56B | $26.77B | $25.06B | $22.98B | $49.11B | $47.31B | $21.36B | $20.39B | $17.97B | $16.80B | $14.65B |
Total Current Liabilities | $103.77B | $101.56B | $104.67B | $104.43B | $99.05B | $114.18B | $112.98B | $116.48B | $89.24B | $100.94B | $88.70B | $88.17B | $78.29B | $79.58B | $76.56B | $80.64B | $72.42B | $66.60B | $69.88B | $78.61B |
Long Term Debt | $- | $74.10B | $63.73B | $63.85B | $62.12B | $58.08B | $59.27B | $60.66B | $58.35B | $45.44B | $45.80B | $40.80B | $45.79B | $43.34B | $44.35B | $37.42B | $43.09B | $39.90B | $39.90B | $35.78B |
Deferred Revenue Non-Current | $- | $- | $-18.43B | $3.21B | $3.35B | $-2.21B | $-2.50B | $14.49B | $2.77B | $1.66B | $2.21B | $2.67B | $3.27B | $-3.65B | $-3.64B | $-3.60B | $3.37B | $-3.34B | $-3.29B | $-3.03B |
Deferred Tax Liabilities Non-Current | $- | $- | $3.63B | $4.17B | $7.72B | $2.21B | $2.50B | $2.83B | $2.77B | $1.66B | $2.58B | $2.95B | $3.27B | $3.65B | $3.64B | $3.60B | $3.37B | $3.34B | $3.29B | $3.03B |
Other Non-Current Liabilities | $- | $19.19B | $14.79B | $14.84B | $11.94B | $13.62B | $13.26B | $13.08B | $8.70B | $12.11B | $11.97B | $11.67B | $9.08B | $11.84B | $12.43B | $12.93B | $8.39B | $11.19B | $11.06B | $10.05B |
Total Non-Current Liabilities | $- | $93.29B | $63.73B | $82.86B | $80.44B | $73.90B | $75.03B | $76.58B | $70.12B | $59.21B | $60.35B | $55.42B | $57.44B | $58.84B | $60.41B | $53.95B | $54.33B | $54.42B | $54.24B | $48.86B |
Other Liabilities | $- | $- | $18.43B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $- | $194.85B | $186.82B | $187.29B | $179.50B | $188.08B | $188.01B | $193.06B | $159.36B | $160.14B | $149.04B | $143.59B | $135.73B | $138.41B | $136.97B | $134.59B | $126.75B | $121.02B | $124.13B | $127.46B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $- | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $9.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M |
Retained Earnings | $- | $96.52B | $92.40B | $90.12B | $95.77B | $93.17B | $89.99B | $88.85B | $86.16B | $83.72B | $80.54B | $78.78B | $77.13B | $75.12B | $73.09B | $71.22B | $69.30B | $69.72B | $67.78B | $62.33B |
Accumulated Other Comprehensive Income Loss | $- | $-2.45B | $-3.42B | $-3.44B | $-7.03B | $-8.69B | $-7.65B | $-7.55B | $-8.39B | $-9.09B | $-7.73B | $-6.03B | $-5.38B | $-4.86B | $-4.09B | $-4.83B | $-3.81B | $-4.49B | $-4.55B | $-5.36B |
Other Total Stockholders Equity | $- | $5.81B | $373.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $388.00M | $- |
Total Stockholders Equity | $- | $99.88B | $84.80B | $86.69B | $88.76B | $84.49B | $82.35B | $81.31B | $77.77B | $74.65B | $72.82B | $72.77B | $71.76B | $70.28B | $69.01B | $66.40B | $65.49B | $65.23B | $63.62B | $56.98B |
Total Equity | $4.32B | $104.45B | $94.68B | $96.92B | $98.92B | $93.98B | $92.16B | $90.62B | $86.35B | $82.92B | $81.13B | $77.65B | $76.48B | $74.63B | $73.32B | $70.58B | $70.54B | $69.95B | $68.36B | $61.60B |
Total Liabilities and Stockholders Equity | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | $221.24B | $212.21B | $213.04B | $210.29B | $205.17B | $197.29B | $190.97B | $192.48B | $189.07B |
Minority Interest | $4.32B | $4.57B | $9.88B | $10.23B | $10.16B | $9.49B | $9.80B | $9.31B | $8.57B | $8.28B | $8.31B | $4.88B | $4.72B | $4.35B | $4.31B | $4.18B | $5.05B | $4.72B | $4.73B | $4.63B |
Total Liabilities and Total Equity | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | $221.24B | $212.21B | $213.04B | $210.29B | $205.17B | $197.29B | $190.97B | $192.48B | $189.07B |
Total Investments | $52.35B | $53.42B | $51.15B | $9.80B | $4.20B | $45.47B | $45.99B | $93.38B | $71.64B | $45.24B | $45.78B | $45.27B | $45.65B | $47.56B | $46.79B | $45.37B | $44.10B | $42.44B | $40.04B | $39.45B |
Total Debt | $4.54B | $78.01B | $75.10B | $73.64B | $67.44B | $63.37B | $65.59B | $70.59B | $57.62B | $48.67B | $51.39B | $47.49B | $46.00B | $46.97B | $48.22B | $46.26B | $43.47B | $43.79B | $46.06B | $51.61B |
Net Debt | $-24.57B | $45.61B | $48.81B | $45.22B | $42.01B | $24.45B | $19.31B | $24.09B | $34.26B | $9.82B | $26.78B | $22.01B | $24.63B | $25.88B | $28.38B | $26.30B | $26.55B | $26.24B | $23.73B | $30.04B |
Annual Cash Flow
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Net Income | $15.24B | $22.38B | $20.64B | $17.73B | $15.77B |
Depreciation and Amortization | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B |
Deferred Income Tax | $- | $-245.00M | $-1.00B | $-814.00M | $-60.00M |
Stock Based Compensation | $1.02B | $1.06B | $925.00M | $800.00M | $679.00M |
Change in Working Capital | $- | $1.64B | $2.25B | $1.52B | $2.90B |
Accounts Receivables | $- | $-3.11B | $-2.52B | $-1.00B | $-688.00M |
Inventory | $- | $1.04B | $- | $-1.03B | $-2.19B |
Accounts Payables | $- | $3.52B | $1.96B | $3.86B | $5.50B |
Other Working Capital | $- | $203.00M | $2.81B | $-310.00M | $278.00M |
Other Non Cash Items | $3.85B | $258.00M | $7.24B | $6.64B | $6.77B |
Net Cash Provided by Operating Activities | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B |
Investments in Property Plant and Equipment | $-3.50B | $-3.39B | $-2.80B | $-2.45B | $-2.05B |
Acquisitions Net | $-13.41B | $-10.14B | $-21.46B | $-4.82B | $-7.14B |
Purchases of Investments | $525.00M | $-18.31B | $-6.84B | $-1.84B | $-2.84B |
Sales Maturities of Investments | $- | $16.54B | $11.99B | $15.30B | $13.74B |
Other Investing Activities | $-4.14B | $-275.00M | $-9.37B | $-16.55B | $-14.25B |
Net Cash Used for Investing Activities | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B |
Debt Repayment | $- | $4.28B | $12.54B | $2.48B | $1.71B |
Common Stock Issued | $- | $1.35B | $1.25B | $1.35B | $1.44B |
Common Stock Repurchased | $-9.00B | $-8.00B | $-7.00B | $-5.00B | $-4.25B |
Dividends Paid | $-7.53B | $-6.76B | $-5.99B | $-5.28B | $-4.58B |
Other Financing Activities | $4.02B | $-2.40B | $3.43B | $-1.01B | $2.09B |
Net Cash Used Provided by Financing Activities | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B |
Effect of Forex Changes on Cash | $-61.00M | $97.00M | $34.00M | $-62.00M | $-116.00M |
Net Change in Cash | $-115.00M | $2.06B | $1.99B | $4.45B | $5.94B |
Cash at End of Period | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B |
Cash at Beginning of Period | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B |
Operating Cash Flow | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B |
Capital Expenditure | $-3.50B | $-3.39B | $-2.80B | $-2.45B | $-2.05B |
Free Cash Flow | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B |
Cash Flow Charts
Breakdown | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $6.05B | $4.22B | $-1.41B | $5.46B | $6.04B | $5.66B | $5.77B | $4.91B | $5.38B | $5.20B | $5.15B | $4.19B | $4.19B | $4.37B | $4.98B | $2.35B | $3.26B | $6.70B | $3.46B | $3.67B |
Depreciation and Amortization | $1.04B | $1.02B | $997.00M | $974.00M | $1.01B | $1.02B | $970.00M | $982.00M | $828.00M | $802.00M | $788.00M | $771.00M | $796.00M | $778.00M | $758.00M | $732.00M | $719.00M | $717.00M | $723.00M | $718.00M |
Deferred Income Tax | $124.00M | $-331.00M | $-27.00M | $249.00M | $-71.00M | $-241.00M | $-263.00M | $-414.00M | $-790.00M | $-176.00M | $178.00M | $-992.00M | $65.00M | $-173.00M | $286.00M | $-227.00M | $-71.00M | $-9.00M | $247.00M | $128.00M |
Stock Based Compensation | $237.00M | $222.00M | $372.00M | $208.00M | $247.00M | $242.00M | $362.00M | $250.00M | $171.00M | $205.00M | $299.00M | $209.00M | $165.00M | $170.00M | $256.00M | $152.00M | $139.00M | $157.00M | $231.00M | $172.00M |
Change in Working Capital | $6.82B | $-91.00M | $-6.24B | $-11.85B | $-410.00M | $4.42B | $9.48B | $-10.26B | $12.96B | $643.00M | $-1.09B | $-961.00M | $2.36B | $393.00M | $-273.00M | $3.09B | $-916.00M | $2.44B | $-1.72B | $1.52B |
Accounts Receivables | $2.47B | $3.69B | $-6.16B | $-540.00M | $-2.77B | $4.50B | $-4.31B | $40.00M | $1.64B | $317.00M | $-4.52B | $-153.00M | $371.00M | $1.68B | $-2.90B | $-494.00M | $245.00M | $2.21B | $-2.65B | $-795.00M |
Inventory | $- | $- | $- | $-441.00M | $1.07B | $-185.00M | $- | $- | $- | $- | $- | $404.00M | $88.00M | $-568.00M | $-955.00M | $502.00M | $1.09B | $465.00M | $-4.25B | $618.00M |
Accounts Payables | $- | $267.00M | $-231.00M | $1.15B | $823.00M | $-249.00M | $4.26B | $-3.64B | $772.00M | $218.00M | $4.44B | $-1.23B | $1.71B | $-454.00M | $3.84B | $2.67B | $-2.41B | $-19.00M | $5.26B | $1.63B |
Other Working Capital | $4.34B | $-563.00M | $9.00M | $-12.02B | $466.00M | $353.00M | $9.53B | $-6.66B | $10.54B | $-518.00M | $-1.01B | $21.00M | $192.00M | $-262.00M | $-261.00M | $410.00M | $164.00M | $-217.00M | $-79.00M | $70.00M |
Other Non Cash Items | $-328.00M | $3.64B | $9.79B | $-226.00M | $91.00M | $-69.00M | $2.20B | $1.95B | $1.16B | $198.00M | $2.17B | $879.00M | $1.93B | $1.66B | $-55.00M | $-100.00M | $-76.00M | $79.00M | $45.00M | $75.00M |
Net Cash Provided by Operating Activities | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | $6.87B | $5.32B | $3.22B | $7.58B | $5.54B | $6.00B | $6.10B | $3.13B | $10.00B | $2.94B | $6.21B |
Investments in Property Plant and Equipment | $-991.00M | $-853.00M | $-743.00M | $-959.00M | $-838.00M | $-829.00M | $-760.00M | $-866.00M | $-724.00M | $-657.00M | $-555.00M | $-695.00M | $-629.00M | $-562.00M | $-568.00M | $-574.00M | $-557.00M | $-451.00M | $-469.00M | $-650.00M |
Acquisitions Net | $-8.64B | $-25.00M | $-3.01B | $-1.79B | $-228.00M | $-335.00M | $-7.83B | $-14.30B | $-4.00M | $-5.92B | $-1.23B | $-94.00M | $-85.00M | $-3.45B | $-1.19B | $-2.81B | $-374.00M | $-3.02B | $-929.00M | $-143.00M |
Purchases of Investments | $-9.82B | $-5.33B | $-4.80B | $-5.32B | $6.38B | $3.32B | $-2.32B | $-2.77B | $-701.00M | $-3.92B | $-1.63B | $1.86B | $5.14B | $-4.24B | $-4.61B | $-1.45B | $5.03B | $-2.55B | $-3.87B | $-476.00M |
Sales Maturities of Investments | $11.89B | $4.62B | $5.29B | $6.39B | $-7.65B | $-2.58B | $2.58B | $1.87B | $4.58B | $2.19B | $3.35B | $6.17B | $3.07B | $3.16B | $2.90B | $3.56B | $3.20B | $543.00M | $30.00M | $4.27B |
Other Investing Activities | $1.91B | $-5.83B | $-3.08B | $-239.00M | $-297.00M | $-309.00M | $-2.69B | $699.00M | $-4.00B | $-277.00M | $-3.60B | $-6.53B | $-9.38B | $-416.00M | $-232.00M | $-3.90B | $-10.16B | $2.52B | $3.70B | $-4.39B |
Net Cash Used for Investing Activities | $-5.65B | $-7.42B | $-6.34B | $-1.92B | $-2.64B | $-728.00M | $-11.02B | $-15.37B | $-847.00M | $-8.59B | $-3.67B | $716.00M | $-1.88B | $-5.50B | $-3.71B | $-5.18B | $-2.87B | $-2.95B | $-1.53B | $-1.39B |
Debt Repayment | $2.33B | $1.43B | $11.36B | $-1.57B | $-1.85B | $-4.68B | $12.38B | $8.73B | $-2.36B | $4.11B | $2.05B | $-1.25B | $-1.12B | $-750.00M | $2.91B | $-355.00M | $-2.27B | $-5.58B | $10.80B | $-500.00M |
Common Stock Issued | $867.00M | $258.00M | $486.00M | $314.00M | $411.00M | $284.00M | $344.00M | $169.00M | $328.00M | $205.00M | $551.00M | $278.00M | $313.00M | $328.00M | $436.00M | $234.00M | $336.00M | $313.00M | $557.00M | $297.00M |
Common Stock Repurchased | $-956.00M | $- | $-3.07B | $-1.50B | $-1.50B | $-3.00B | $-2.00B | $-1.00B | $-1.00B | $-2.50B | $-2.50B | $-1.05B | $-1.05B | $-1.25B | $-1.65B | $-1.71B | $-850.00M | $- | $-1.69B | $-399.00M |
Dividends Paid | $-1.94B | $-1.94B | $-1.73B | $-1.74B | $-1.74B | $-1.75B | $-1.54B | $-1.54B | $-1.54B | $-1.54B | $-1.36B | $-1.36B | $-1.37B | $-1.37B | $-1.18B | $-1.18B | $-1.19B | $-1.19B | $-1.02B | $-1.02B |
Other Financing Activities | $-2.51B | $-945.00M | $1.18B | $-1.93B | $-2.43B | $-1.32B | $4.01B | $-1.97B | $1.15B | $672.00M | $3.57B | $-238.00M | $-1.17B | $2.82B | $275.00M | $1.42B | $-1.04B | $178.00M | $664.00M | $-4.59B |
Net Cash Used Provided by Financing Activities | $-2.21B | $-1.20B | $8.23B | $-6.43B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | $946.00M | $2.30B | $-3.63B | $-4.40B | $-218.00M | $787.00M | $-1.60B | $-5.02B | $-6.28B | $9.30B | $-6.21B |
Effect of Forex Changes on Cash | $14.00M | $4.00M | $-48.00M | $48.00M | $-57.00M | $55.00M | $51.00M | $30.00M | $-53.00M | $-100.00M | $157.00M | $-17.00M | $-51.00M | $57.00M | $-51.00M | $44.00M | $-17.00M | $-14.00M | $-129.00M | $17.00M |
Net Change in Cash | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100.00M | $18.55B | $-15.48B | $14.23B | $-870.00M | $4.11B | $290.00M | $1.25B | $-123.00M | $3.03B | $-629.00M | $-4.78B | $758.00M | $10.58B | $-1.38B |
Cash at End of Period | $32.40B | $26.29B | $28.41B | $25.43B | $38.91B | $41.81B | $41.91B | $23.36B | $38.84B | $24.61B | $25.48B | $21.38B | $21.09B | $19.83B | $19.95B | $16.92B | $17.55B | $22.33B | $21.57B | $10.98B |
Cash at Beginning of Period | $26.29B | $28.41B | $25.43B | $38.91B | $41.81B | $41.91B | $23.36B | $38.84B | $24.61B | $25.48B | $21.38B | $21.09B | $19.83B | $19.95B | $16.92B | $17.55B | $22.33B | $21.57B | $10.98B | $12.36B |
Operating Cash Flow | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | $6.87B | $5.32B | $3.22B | $7.58B | $5.54B | $6.00B | $6.10B | $3.13B | $10.00B | $2.94B | $6.21B |
Capital Expenditure | $-991.00M | $-853.00M | $-743.00M | $-959.00M | $-838.00M | $-829.00M | $-760.00M | $-866.00M | $-724.00M | $-657.00M | $-555.00M | $-695.00M | $-629.00M | $-562.00M | $-568.00M | $-574.00M | $-557.00M | $-451.00M | $-469.00M | $-650.00M |
Free Cash Flow | $12.95B | $5.89B | $401.00M | $-6.15B | $6.06B | $10.20B | $15.57B | $-5.40B | $17.82B | $6.21B | $4.76B | $2.52B | $6.95B | $4.98B | $5.44B | $5.53B | $2.57B | $9.55B | $2.47B | $5.55B |
UnitedHealth Group Stock Forecast
Analyst ratings, price targets, and earnings estimates for UNH.
UNH Analyst Ratings
Strong Buy
Based on 32 analysts in the past 3 months
UNH Stock 12 Month Forecast
$635.00
Based on 1 analysts in the last 3 months
Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Revenue Estimates
Net Income Estimates
EPS Estimates
Latest Price Target Updates
Date | Analyst | Firm | Price Target | Price When Posted | Upside |
---|---|---|---|---|---|
Dec 09, 2024 | David Windley | Jefferies | $635.00 | $549.53 | 15.6% |
Oct 16, 2024 | Ben Hendrix | RBC Capital | $595.00 | $556.29 | 7.0% |
Oct 16, 2024 | David MacDonald | Truist Financial | $625.00 | $556.29 | 12.4% |
Oct 16, 2024 | Joanna Gajuk | Bank of America Securities | $650.00 | $556.29 | 16.8% |
Oct 16, 2024 | David Windley | Jefferies | $643.00 | $556.29 | 15.6% |
Oct 16, 2024 | George Hill | Deutsche Bank | $595.00 | $556.29 | 7.0% |
Oct 16, 2024 | Matthew Gillmor | KeyBanc | $650.00 | $569.66 | 14.1% |
Oct 10, 2024 | Matthew Gillmor | KeyBanc | $675.00 | $597.70 | 12.9% |
Jul 17, 2024 | David Toung | Argus Research | $600.00 | $565.78 | 6.0% |
Jul 17, 2024 | David MacDonald | Truist Financial | $640.00 | $548.87 | 16.6% |
UnitedHealth Group Dividends
Explore UnitedHealth Group's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.60%
Dividend Payout Ratio
52.29%
Dividend Paid & Capex Coverage Ratio
2.19x
UnitedHealth Group Dividend History
Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|
$2.1 | $2.1 | December 09, 2024 | December 09, 2024 | December 17, 2024 | November 06, 2024 |
$2.1 | $2.1 | September 16, 2024 | September 16, 2024 | December 17, 2024 | November 06, 2024 |
$2.1 | $2.1 | June 17, 2024 | June 17, 2024 | June 25, 2024 | June 05, 2024 |
$1.88 | $1.88 | March 08, 2024 | March 11, 2024 | March 19, 2024 | February 23, 2024 |
$1.88 | $1.88 | December 01, 2023 | December 04, 2023 | December 12, 2023 | November 08, 2023 |
$1.88 | $1.88 | September 08, 2023 | September 11, 2023 | September 19, 2023 | August 23, 2023 |
$1.88 | $1.88 | June 15, 2023 | June 19, 2023 | June 27, 2023 | June 07, 2023 |
$1.65 | $1.65 | March 10, 2023 | March 13, 2023 | March 21, 2023 | February 27, 2023 |
$1.65 | $1.65 | December 02, 2022 | December 05, 2022 | December 13, 2022 | November 04, 2022 |
$1.65 | $1.65 | September 09, 2022 | September 12, 2022 | September 20, 2022 | August 17, 2022 |
$1.65 | $1.65 | June 16, 2022 | June 20, 2022 | June 28, 2022 | June 08, 2022 |
$1.45 | $1.45 | March 11, 2022 | March 14, 2022 | March 22, 2022 | February 16, 2022 |
$1.45 | $1.45 | December 03, 2021 | December 06, 2021 | December 14, 2021 | November 05, 2021 |
$1.45 | $1.45 | September 10, 2021 | September 13, 2021 | September 21, 2021 | August 11, 2021 |
$1.45 | $1.45 | June 18, 2021 | June 21, 2021 | June 29, 2021 | June 09, 2021 |
$1.25 | $1.25 | March 12, 2021 | March 15, 2021 | March 23, 2021 | February 24, 2021 |
$1.25 | $1.25 | December 04, 2020 | December 07, 2020 | December 15, 2020 | November 04, 2020 |
$1.25 | $1.25 | September 11, 2020 | September 14, 2020 | September 22, 2020 | August 05, 2020 |
$1.25 | $1.25 | June 19, 2020 | June 22, 2020 | June 30, 2020 | June 02, 2020 |
$1.08 | $1.08 | March 13, 2020 | March 16, 2020 | March 24, 2020 | February 17, 2020 |
Peers: Medical - Healthcare Plans
This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.
Company | Market Cap | Price | EPS | P/E Ratio | P/B Ratio |
---|---|---|---|---|---|
![]() Cigna Corporation
CI
|
$79.43B | $285.57 | $17.57 | $17.04 | $1.90 |
![]() Humana Inc.
HUM
|
$33.59B | $278.93 | $20.09 | $22.78 | $3.49 |
![]() Elevance Health Inc.
ELV
|
$90.37B | $389.67 | $25.62 | $14.40 | $0.00 |
![]() Centene Corporation
CNC
|
$29.51B | $58.45 | $6.33 | $9.56 | $0.00 |
![]() Molina Healthcare, Inc.
MOH
|
$16.24B | $284.00 | $20.43 | $14.24 | $0.00 |
![]() CVS Health Corporation
CVS
|
$68.60B | $54.51 | $6.49 | $12.16 | $1.33 |
![]() Alignment Healthcare, Inc.
ALHC
|
$2.86B | $14.94 | $-0.79 | $-10.83 | $10.22 |
Related Metrics
Explore detailed financial metrics and analysis for UNH.